Hjem › Ulcerøs kolitt › Texas › Lubbock
Kliniske studier for Ulcerøs kolitt i Lubbock, TX
9 studier for Ulcerøs kolitt søker deltakere på steder i og rundt Lubbock (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)
RekruttererFase 3
- GI Alliance - Lubbock ( Site 0288), Lubbock
- Caprock Gastro Research ( Site 0293), Lubbock
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
RekruttererFase 2
- GI Alliance - Lubbock /ID# 283920, Lubbock
- Caprock Gastro Research - Lubbock /ID# 283921, Lubbock
A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
RekruttererFase 4
- West Texas Research Institute, Lubbock
Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
RekruttererFase 1/2Frivillige helsepersonell ønskes velkommen
- Xencor Investigative Site, Lubbock
A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis
RekruttererFase 2
- Site US-015, Lubbock
LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
RekruttererFase 2
- GI Alliance - Lubbock, Lubbock
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
RekruttererFase 3
- GI Alliance - Lubbock - Site Number: 8400092, Lubbock
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
RekruttererFase 3
- Texas Digestive Disease Consultants dba GI Alliance - Lubbock - Site Number: 8400092, Lubbock
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
RekruttererFase 2
- Mirador Therapeutics Selected Site, Lubbock
Ulcerøs kolitt-studier i andre byer
- New York City, NY23 studier
- Orlando, FL22 studier
- Miami, FL21 studier
- Houston, TX17 studier
- San Antonio, TX16 studier
- Chicago, IL15 studier
- Tacoma, WA15 studier
- San Diego, CA15 studier
- Tyler, TX14 studier
- Colorado Springs, CO14 studier
- Los Angeles, CA13 studier
- St. Louis, MO13 studier
Andre studier i Lubbock
- Crohns sykdom10 studier
- Brystkreft6 studier
- Ikke-småcellet lungekreft4 studier
- Psoriasisartritt3 studier
- Slag3 studier
- Overvekt3 studier
- Fedme3 studier
- Inflammatorisk tarmsykdom3 studier
- Burkitts lymfom3 studier
- Multipelt myelom3 studier
Fra ClinicalTrials.gov, data hentet 4. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.